These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 11265428

  • 1. [Blood and blood product transfusions. Immunological basis and indications].
    Andreu G.
    Rev Prat; 2001 Feb 15; 51(3):299-305. PubMed ID: 11265428
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunological consequences of blood transfusions.
    Claas FH, Lagaay EL, van Rood JJ.
    Schweiz Med Wochenschr Suppl; 1991 Feb 15; 43():70-2. PubMed ID: 1688196
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Patients with anti-Vel--immunohematological characterization and transfusion management.
    Lynen R, Simson G, Quentin SH, Schulte B, The LG, Neumeyer H.
    Beitr Infusionsther; 1990 Feb 15; 26():377-9. PubMed ID: 1703877
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Immune safety in blood transfusions].
    Chiaroni J, Legrand D.
    Rev Prat; 2001 Jun 30; 51(12):1311-7. PubMed ID: 11503504
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Xg blood group system and anti-Xg(a) antibody].
    Tamaki T, Kawaguchi H, Tanaka T.
    Nihon Rinsho; 2005 Jul 30; 63 Suppl 7():704-6. PubMed ID: 16111374
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Platelet and granulocyte transfusion in hematology].
    Ouellet P.
    Union Med Can; 1983 May 30; 112(5):457-60. PubMed ID: 6879858
    [No Abstract] [Full Text] [Related]

  • 16. [Immunological safety in transfusions].
    Rodet M.
    Rev Infirm; 1991 Mar 30; 41(5):51-3. PubMed ID: 1896742
    [No Abstract] [Full Text] [Related]

  • 17. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R, Endert G, Lammel G.
    Z Arztl Fortbild (Jena); 1984 Mar 30; 78(20):849-52. PubMed ID: 6523909
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of HLA sensibilization].
    Timoshenko LI, Baĭ EN, Babiĭ ZN, Burka NI, Krishtof AN.
    Vrach Delo; 1982 Mar 30; (10):52-4. PubMed ID: 7179881
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.